TY - JOUR
T1 - Second-Generation Antidepressants and Hyponatremia Risk
T2 - A Population-Based Cohort Study of Older Adults
AU - Gandhi, Sonja
AU - Shariff, Salimah Z.
AU - Al-Jaishi, Ahmed
AU - Reiss, Jeffrey P.
AU - Mamdani, Muhammad M.
AU - Hackam, Daniel G.
AU - Li, Lihua
AU - McArthur, Eric
AU - Weir, Matthew A.
AU - Garg, Amit X.
N1 - Publisher Copyright:
© 2016 National Kidney Foundation, Inc.
PY - 2017/1/1
Y1 - 2017/1/1
N2 - Background Hyponatremia may occur after initiation of a second-generation antidepressant drug. However, the magnitude of this risk among older adults in routine care is not well characterized. Study Design Retrospective, population-based, matched-cohort study. Setting & Participants In Ontario, Canada, 2003 to 2012, we compared older adults with a mood or anxiety disorder who were dispensed 1 of 9 second-generation antidepressant drugs with matched adults with comparable indicators of baseline health who were not dispensed an antidepressant drug (n = 138,246 per group). A similar comparison was made in a subpopulation with available laboratory data (n = 4,186 per group). Predictor Second-generation antidepressant prescription versus no antidepressant prescription. Outcomes The primary outcome was hospitalization with hyponatremia. A secondary outcome was hospitalization with both hyponatremia and delirium. Measurements We assessed hospitalization with hyponatremia using a diagnosis code and, in the subpopulation, serum sodium values. We assessed hospitalization with hyponatremia and delirium using a combination of diagnosis codes. Results Second-generation antidepressant use versus nonuse was associated with higher 30-day risk for hospitalization with hyponatremia (450/138,246 [0.33%] vs 84/138,246 [0.06%]; relative risk [RR], 5.46 [95% CI, 4.32-6.91]). This association was consistent in the subpopulation with serum sodium values (73/4,186 [1.74%] vs 18/4,186 [0.43%]; RR, 4.23 [95% CI, 2.50-7.19]; absolute risk increase, 1.31% [95% CI, 0.87%-1.75%]). Second-generation antidepressant use versus nonuse was also associated with higher 30-day risk for hospitalization with both hyponatremia and delirium (28/138,246 [0.02%] vs 7/138,246 [0.005%]; RR, 4.00 [95% CI, 1.75-9.16]). Limitations Measures of serum sodium could be ascertained in only a subpopulation. Conclusions Use of a second-generation antidepressant in routine care by older adults is associated with an approximate 5-fold increase in 30-day risk for hospitalization with hyponatremia compared to nonuse. However, the absolute increase in 30-day incidence is low.
AB - Background Hyponatremia may occur after initiation of a second-generation antidepressant drug. However, the magnitude of this risk among older adults in routine care is not well characterized. Study Design Retrospective, population-based, matched-cohort study. Setting & Participants In Ontario, Canada, 2003 to 2012, we compared older adults with a mood or anxiety disorder who were dispensed 1 of 9 second-generation antidepressant drugs with matched adults with comparable indicators of baseline health who were not dispensed an antidepressant drug (n = 138,246 per group). A similar comparison was made in a subpopulation with available laboratory data (n = 4,186 per group). Predictor Second-generation antidepressant prescription versus no antidepressant prescription. Outcomes The primary outcome was hospitalization with hyponatremia. A secondary outcome was hospitalization with both hyponatremia and delirium. Measurements We assessed hospitalization with hyponatremia using a diagnosis code and, in the subpopulation, serum sodium values. We assessed hospitalization with hyponatremia and delirium using a combination of diagnosis codes. Results Second-generation antidepressant use versus nonuse was associated with higher 30-day risk for hospitalization with hyponatremia (450/138,246 [0.33%] vs 84/138,246 [0.06%]; relative risk [RR], 5.46 [95% CI, 4.32-6.91]). This association was consistent in the subpopulation with serum sodium values (73/4,186 [1.74%] vs 18/4,186 [0.43%]; RR, 4.23 [95% CI, 2.50-7.19]; absolute risk increase, 1.31% [95% CI, 0.87%-1.75%]). Second-generation antidepressant use versus nonuse was also associated with higher 30-day risk for hospitalization with both hyponatremia and delirium (28/138,246 [0.02%] vs 7/138,246 [0.005%]; RR, 4.00 [95% CI, 1.75-9.16]). Limitations Measures of serum sodium could be ascertained in only a subpopulation. Conclusions Use of a second-generation antidepressant in routine care by older adults is associated with an approximate 5-fold increase in 30-day risk for hospitalization with hyponatremia compared to nonuse. However, the absolute increase in 30-day incidence is low.
KW - Hyponatremia
KW - antidepressants
KW - anxiety disorder
KW - citalopram
KW - duloxetine
KW - electrolyte disorder
KW - escitalopram
KW - fluoxetine
KW - fluvoxamine
KW - mirtazapine
KW - mood disorder
KW - older adults
KW - paroxetine
KW - second-generation antidepressant
KW - sertraline
KW - serum sodium
KW - syndrome of inappropriate antidiuretic hormone secretion (SIADH)
KW - venlafaxine
UR - http://www.scopus.com/inward/record.url?scp=85006513869&partnerID=8YFLogxK
U2 - 10.1053/j.ajkd.2016.08.020
DO - 10.1053/j.ajkd.2016.08.020
M3 - Article
C2 - 27773479
AN - SCOPUS:85006513869
SN - 0272-6386
VL - 69
SP - 87
EP - 96
JO - American Journal of Kidney Diseases
JF - American Journal of Kidney Diseases
IS - 1
ER -